Rheonix to Showcase Breakthrough Technology That Addresses Obstacles in Molecular Testing at AACC Clinical Lab Expo

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will showcase its breakthrough molecular testing platform, the Encompass Optimum™ , at the American Association of Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Expo. The platform, for research use only, performs fully automated, complex molecular assays in an easy-to-use and economical format, addressing workflow and staffing obstacles laboratories face today. The AACC Clinical Lab Expo will be held in Atlanta, July 26-30.

Research laboratories in the U.S. and abroad are constrained by a lack of qualified personnel and highly specialized technicians to fill a growing number of professional laboratory positions. The U.S. Bureau of Labor Statistics reports the number of medical laboratory technologist and technician positions is expected to increase to more than 373,500 by 2020, an increase of 13 percent from 2010. Many positions remain unfilled as over half of all laboratories are reporting difficulty hiring laboratory personnel, an issue that is compounded by an aging workforce. The national average age of the laboratory workforce in 2010 was 49.2, compared with 43.6 just four years prior, according to the American Society for Clinical Pathology (ASCP). Additionally, the ASCP reports the number of laboratory training programs decreased by almost 25 percent from 1990 to 2010 and the number of individuals graduating from these programs also declined.

The Rheonix Encompass Optimum was recently featured in GenomeWeb for its ability to meet research laboratories’ demand for more sophisticated tests and technology that is capable of high throughput, high complexity and improved workflow efficiencies with minimum user intervention.

“Obstacles facing research labs today, such as inefficient workflow and a lack of trained staff, create an environment that is receptive to workforce multipliers and automated systems like the Encompass Optimum,” said Steve Pemberton, vice president of marketing and sales, Rheonix. “It is a first-of-akind system that incorporates totally open software, enabling laboratories to build their own assays and greatly simplify the testing process.”

The Encompass Optimum is an automated system that streamlines workflow for building and implementing molecular assays as a nonclinical tool. It is a platform with unmatched versatility that allows users the flexibility to configure their own testing and control all aspects of assay performance, while keeping the testing simple and maintaining the instrument’s ease of use. The Encompass Optimum allows users to create their own sample-to-answer, fully automated, complex molecular assays in an easy-to-use format using the Rheonix CARD® cartridge. The cartridge, the size of a smartphone, can run several biological samples through a fully integrated molecular analysis with no user intervention—it automatically manipulates the network of microfluidic pumps to move fluids through the channels of the CARD. The Encompass Optimum can dramatically decrease the complexities of creating user-defined testing, while increasing efficiency and accuracy. The product’s automation, capability for high throughput and high-complexity assays, and unique sample-to-result system allows the platform to solve workflow inefficiencies within many research labs.

Held in the Georgia World Congress Center, the Clinical Lab Expo is the leading event for laboratory medicine worldwide. At this meeting, breakthrough innovations in clinical testing, patient care and nonclinical testing and research are introduced to the health care world. Attendees can hear about vital research and important changes in the field and discover cutting-edge diagnostic technology.

Attendees are invited to stop by booth 2052 to talk to the Rheonix team and learn more about the company’s technology.

For more information, visit www.rheonix.com